LexaGene Life Sciences CF Investors, Inc. — Form C (Regulation Crowdfunding)

LexaGene Life Sciences CF Investors, Inc. of DALLAS, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2023-10-31. Target raise $26K, up to $5.0M. Offered through DEALMAKER SECURITIES LLC.

Offering

• Filed: 2023-10-31
• Form: C
• Accession: 0001104659-23-112915
• Target amount: $26K
• Maximum amount: $5.0M
• Security type: Common Stock
• Securities offered: 25,750
• Price: $1.0300
• Deadline: 2024-10-31
• Funding portal / intermediary: DEALMAKER SECURITIES LLC
• Intermediary file number: 008-70756
• Intermediary CRD: 315324

Issuer

• CIK: 0001998226
• Legal status: Corporation
• Organized in: DE
• Incorporated: 2023-08-18
• Address: 3811 TURTLE CREEK BLVD., STE 875, DALLAS, TX, 75219
• Employees: 0

Financials (as filed)

• Total assets (most recent): $65K
• Cash (most recent): $1K
• Net income (most recent): $11K

People (2)

More

• CIK 1998226 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search